A typical IVF cycle in the US lists at $20,000 to $30,000 before medications, and most patients need more than one cycle. Surrogacy with an agency in California or Texas now runs $130,000 to $200,000 all in. For a lot of would-be parents — single people, same-sex couples, people whose insurance doesn't touch fertility, people who've already done two or three rounds at home — those numbers don't work, and the question becomes whether the same outcome is buyable for less somewhere else.
It often is. A monitored IVF cycle in Prague or Barcelona costs around $4,000 to $6,000. Surrogacy in Georgia or Mexico runs roughly a third of the US price. There are real, well-equipped clinics. There are also real reasons several countries that used to be cheap surrogacy hubs aren't anymore — and in most cases they shut down for the same kind of reason.
This piece is descriptive, not prescriptive. We're not telling anyone whether to book a flight. We're laying out what the price differential actually is, what each country's legal status is right now, and the events from the last decade that explain why some doors closed and why the doors that are open carry a particular set of risks.
The cost differential, plainly
There are two separate markets. IVF tourism is mostly Europeans and North Americans going to Czechia, Spain, Greece, and increasingly Cyprus for cycles using donor eggs or their own. The price gap exists because labor, real estate, and pharma are cheaper, not because the medicine is meaningfully different — many European clinics use the same Vitrolife and Cooper Surgical equipment as US labs.
A rough US-versus-Europe IVF picture in 2024–2025 dollars:
- United States: $20,000–$30,000 per cycle base, plus $4,000–$7,000 in stimulation meds. Donor egg adds $25,000–$45,000.
- Czech Republic: $3,500–$5,500 per cycle, donor egg $5,500–$8,500.
- Spain: $5,000–$8,000 per cycle, donor egg $7,000–$11,000. Strict donor anonymity.
- Greece: $4,500–$7,000 per cycle, donor egg $6,500–$9,500.
- Cyprus (north and south): $4,000–$6,500, donor egg from $6,500. Looser oversight in the north.
Surrogacy is a different conversation. The price isn't mostly a clinic line item — it's the surrogate's compensation, agency fees, legal fees, insurance, and travel. The rough range:
- United States (commercial states like California, Nevada, Illinois): $130,000–$200,000+
- Canada (altruistic-only, expenses reimbursed): $60,000–$90,000
- Mexico (Mexico City, post-2021 ruling): $60,000–$90,000
- Colombia: $50,000–$75,000
- Georgia (Tbilisi): $45,000–$65,000
- Ukraine (Kyiv, BioTexCom and others, wartime pricing): $40,000–$70,000
These are not apples-to-apples. The cheaper packages typically include fewer attempts, less insurance for the surrogate, less postpartum support, and significantly less legal scaffolding for getting the baby home.
IVF tourism: Czech Republic, Spain, Greece
These three are the established European IVF hubs and the most studied. All operate under EU tissue and cell directives, which standardize donor screening and require the same infectious-disease workups as US labs.
Czech Republic is the budget leader. Donor eggs are anonymous by law, supply is good, and the wait for a matched donor is usually weeks rather than months. The catch for some families: anonymous donor systems mean a future child cannot identify the donor — a position that some prospective parents are increasingly uncomfortable with after the rise of consumer DNA testing.
Spain is roughly the volume leader in Europe and also operates anonymous donor egg programs. Spanish law allows donor recipients up to age 50 in most clinics. Single women and same-sex couples can access treatment.
Greece is the legal outlier worth knowing about: Greek law permits surrogacy for foreigners as long as the intended mother has a documented medical inability to carry, a court pre-approves the arrangement, and the surrogate is a permanent resident. Compensation is technically limited to expenses, which keeps prices more like $75,000–$100,000. Greek surrogacy is small-volume and slow but legally clean.
Practical note: success rates published by individual clinics are not directly comparable to SART data because the denominators are defined differently. Ask any clinic for live-birth rate per embryo transfer in your specific age band, not "pregnancy rate per cycle started."
Ukraine: a working surrogacy industry inside a wartime country
Ukraine has been one of the world's largest surrogacy destinations for non-residents for over a decade. Ukrainian law permits commercial gestational surrogacy for heterosexual married couples where the intended mother has a documented medical inability to carry, and — critically — the intended parents are recognized as the legal parents from birth. There is no need for a post-birth adoption step.
Then Russia invaded in February 2022. What happened next was reported widely and is worth describing in plain terms because it shapes the present-day risk picture.
In the first weeks of the war, dozens of newborns were born to Ukrainian surrogates while their intended parents were stuck outside the country. BioTexCom's Kyiv facility moved infants into its underground shelter. Several other clinics evacuated surrogates and newborns westward toward Lviv. There were reported delays in birth registration and in obtaining exit documents while the country was still implementing martial-law procedures.
Three-plus years later, the bigger Kyiv clinics are still operating. Their public statements describe relocated medical operations, expanded shelters, and a continued willingness to take on foreign intended parents. Pricing has come down somewhat from prewar levels.
The risks have not gone away. Air travel into Ukraine is closed; entry is overland through Poland or Moldova. Air-raid warnings disrupt clinic schedules. Anyone considering Ukraine in the present moment has to be ready for the possibility that the legal framework changes mid-pregnancy, and for the possibility that exit logistics fail in ways that have nothing to do with the clinic. (Our companion piece on one family's wartime Kyiv journey walks through what this looks like in practice.)
Georgia: the current Eastern European cost leader
Georgia (the country) has become the destination many former Ukraine clients now use. The legal framework is similar in structure: commercial gestational surrogacy is permitted for married heterosexual couples, and Georgian birth certificates list the intended parents.
Tbilisi has multiple established clinics and a small ecosystem of agencies operating in English and Russian. Cost runs roughly $45,000 to $65,000 all in. The risks specific to Georgia: the legal framework is statutory rather than constitutional, so a future government could compress the timeline for foreigners with relatively little notice; and same-sex couples and single intended parents are not eligible.
Mexico: a fragmented legal map
Mexican surrogacy has gone through three eras. From roughly 2010 to 2015, the state of Tabasco was an open commercial market. In 2016, Tabasco amended its civil code to restrict surrogacy to Mexican heterosexual married couples. The market mostly evaporated overnight.
In 2021, the Mexican Supreme Court issued a ruling (Acción de Inconstitucionalidad 16/2016) that effectively held surrogacy contracts cannot be categorically banned. The ruling reopened a viable path, but it did not create a federal surrogacy framework. What exists is a patchwork: Mexico City and a handful of other jurisdictions are workable; most states still have no positive law.
Costs are around $60,000 to $90,000. The thing to know is that the legal pathway is real but not yet routine — and the speed at which a state government could narrow it again is the same speed Tabasco moved at in 2016.
Colombia, Cyprus, Albania, Kazakhstan: emerging entrants
Colombia has no specific surrogacy law. A Constitutional Court ruling in 2009 (T-968/09) recognized the validity of a surrogacy arrangement after the fact. Costs $50,000–$75,000. The trade-off: "no law" works both ways.
Cyprus has a long-standing IVF tourism industry; surrogacy itself is in a regulatory gray area. Albania has positioned itself as a partner jurisdiction for Ukrainian agencies. Kazakhstan permits commercial surrogacy under a 2011 family code with relatively detailed rules. In all three, the system is newer, the case law thinner, and the agency ecosystem includes both professional operators and people who arrived in the last 18 months.
The ethics history — and the pattern that runs through it
For roughly a decade, four countries served as the volume center of international commercial surrogacy: India, Thailand, Cambodia, and Nepal. All four are now closed to foreign intended parents. They closed in sequence, and the proximate causes were different cases, but the underlying pattern is the same: a permissive market grew faster than the legal scaffolding around it, a high-profile case made the gap between contract and lived reality impossible to ignore, and the government responded with a categorical ban.
Thailand and the Baby Gammy case (2014)
In 2014, a Thai surrogate named Pattaramon Chanbua was carrying twins for an Australian couple. One twin had Down syndrome and a congenital heart defect. According to her account, the intended parents asked her to abort that fetus and, when she refused, took only the healthy twin home. The story broke internationally in July 2014.
Subsequent reporting was more complicated than the headline. None of it rehabilitated the underlying picture: a commercial arrangement built around a healthy outcome had no ready answer when the outcome was complicated, and the surrogate was left holding it.
Thailand's response was the Protection of Children Born from Assisted Reproductive Technologies Act, which took effect July 30, 2015. It restricted surrogacy to Thai heterosexual married couples (one spouse Thai-citizen), banned commercial compensation, and criminalized brokering. Foreign-IP commercial surrogacy in Thailand effectively ended overnight.
India's 2015 directive
India had been the dominant global surrogacy hub through the late 2000s and early 2010s, with an estimated 2,000+ surrogate births per year for foreign IPs at the peak. In November 2015, the Indian government issued a directive instructing the Ministry of Home Affairs to stop issuing medical visas for commercial surrogacy. The final Surrogacy (Regulation) Act 2021 restricts surrogacy in India to altruistic arrangements for Indian married heterosexual couples meeting age and infertility criteria, with no commercial compensation and no foreign access.
Nepal (2015) and Cambodia (2016)
When India closed, agencies relocated to Nepal. After the April 2015 earthquake, Israeli intended parents and their Nepalese-born babies were among the high-profile evacuees. In August 2015, Nepal's Supreme Court ordered an immediate halt to commercial surrogacy.
Cambodia followed almost the same path. In 2016, the Cambodian Ministry of Health issued an order banning commercial surrogacy, and in 2017 prosecutions began under human trafficking statutes. Several intended parents found themselves negotiating exit visas for their newborns under threat of trafficking charges against the surrogate.
The pattern across all four — Thailand, India, Nepal, Cambodia — is the same. A market grew on price. A specific case made the gap between marketing and reality visible. The government responded not by regulating, but by closing. People mid-pregnancy at the moment of closure were the most exposed.
Why the pattern matters today
Mexico (Tabasco), Ukraine (proposed reforms), Georgia (proposed reforms), Thailand, India, Nepal, and Cambodia have all in the last decade gone from open to closed or sharply restricted on a timeline shorter than a typical surrogacy journey. Egg retrieval to delivery is roughly 10–14 months. A government acting on a high-profile case can move faster than that.
The relevant question for any current destination isn't "is this legal today" — it's "what happens to a family mid-pregnancy if the law changes." In most of the historical cases, governments grandfathered ongoing pregnancies. That is not guaranteed. Cambodia did not.
The exit-visa and citizenship layer
A baby born to a foreign surrogate is, depending on the country, sometimes a citizen of nowhere until an embassy issues a passport. The path varies:
- United States: a child born abroad to at least one US-citizen parent who meets physical-presence requirements is a US citizen at birth, but the Consular Report of Birth Abroad (CRBA) and passport process can take 4–12 weeks, and the consulate may require DNA evidence of the genetic relationship.
- United Kingdom: surrogacy contracts are unenforceable; intended parents must apply for a parental order in UK courts within six months of birth. The child travels home on the surrogate's country's passport with a UK visa.
- Germany, France, Italy, Spain: do not recognize foreign commercial surrogacy. Returning families have faced years of legal limbo.
- Australia, Canada, Ireland: vary by state/province. Most require post-birth adoption.
This is the single most under-discussed part of the international decision. The clinic's job ends at delivery. The intended parents' job to physically and legally bring their child home begins there, in a foreign country, with paperwork.
About the people carrying the pregnancy
Cost differentials abroad are not mostly clinic margins — they're labor differentials. A US surrogate is paid $50,000–$70,000 in base compensation. A Ukrainian or Georgian surrogate typically receives $15,000–$25,000. A Mexican or Colombian surrogate receives roughly the same range or slightly less.
Whether that gap is exploitative is a real ethical question, and reasonable people disagree. The arguments on each side, briefly:
On one side: those compensation amounts represent multi-year salaries in the surrogate's home country. They give working-class women access to housing, education, and savings on a scale they couldn't otherwise reach.
On the other side: a market in which the seller is poor and the buyer is rich is, by definition, not a level playing field. The medical decisions during pregnancy sit primarily with the contracting parties, and reporting from former hubs (especially India) repeatedly found surrogates who had not been clearly informed of the procedures done to them.
The relevant test, for any prospective family: ask whether the surrogate has independent legal counsel paid for separately from the agency, whether she can refuse selective reduction, what the agency's policy is when a pregnancy presents unexpected complications, and whether she has health coverage that continues past delivery.
Questions worth asking any international clinic before booking
- What is your live-birth rate per embryo transfer for my age band, in the last 12 months, with my egg source?
- What lab certification do you hold, and when was your last external audit?
- For surrogacy: who is the surrogate's independent lawyer, and is that fee paid separately from the agency package?
- What insurance does the surrogate carry during pregnancy, and what continues past delivery?
- What happens in a fetal-anomaly diagnosis at 12 weeks? At 20 weeks? Whose decision is it?
- What happens if the law in this country changes during my pregnancy?
- What documents do I need to leave the country with my baby, and what is your average timeline from birth to exit?
- Can you connect me, without filtering, with three families from my country who completed a journey with you in the last 18 months?
The honest framing
International IVF and international surrogacy are not the same decision. IVF tourism in established European hubs is a relatively low-risk, well-regulated cost-saving move for many families. International surrogacy is a higher-stakes decision in every direction.
The cost savings are real and large. The legal exposure — to changes in the host country, to delays in citizenship recognition at home, to a system built around a contract whose enforceability varies by jurisdiction — is also real and large. The history of the last decade is a history of governments closing markets faster than ongoing journeys could complete.
None of that means international surrogacy is wrong. Many families have built their lives through it without incident. It does mean the decision is not purely financial, and that the people who present it as a straightforward arbitrage have a financial interest in presenting it that way.